Table II.
Association between survivin expression levels and clinicopathological features of gastric cancer.
| Survivin expression | |||
|---|---|---|---|
| Variable | Low | High | P-value |
| Sex | 0.70a | ||
| Male | 17 | 50 | |
| Female | 19 | 58 | |
| Age, years | 0.86a | ||
| ≤50 | 12 | 35 | |
| >50 | 24 | 73 | |
| Location | 0.11b | ||
| Upper | 18 | 54 | |
| Middle | 17 | 32 | |
| Lower | 0 | 13 | |
| Whole | 0 | 9 | |
| Tumor size, cm | <0.05a | ||
| <5 | 19 | 45 | |
| ≥5 | 17 | 63 | |
| Histological type | 0.84b | ||
| WMD | 8 | 45 | |
| PD | 20 | 58 | |
| SRC | 6 | 0 | |
| MC | 2 | 5 | |
| Serosal invasion | 0.93a | ||
| Absent | 18 | 57 | |
| Present | 18 | 51 | |
| Lymph node metastasis | 0.04a | ||
| Negative | 16 | 18 | |
| Positive | 22 | 90 | |
| Total | 36 | 108 | |
a
χ2
b
Fisher's exact test was used for statistical analysis. WMD, well or moderately differentiated adenocarcinoma; PD, poorly differentiated adenocarcinoma; SRC, signet ring cell carcinoma; MC, mucinous adenocarcinoma.